Douglas C Stafford
Inventor
Stats
- 8 US patents issued
- 15 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 8 US Patents Issued
- 15 US Applications Filed
- 174 Total Citation Count
- Aug 11, 2022 Most Recent Filing
- Sep 13, 1994 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2
| 2013
|
| UWM RESEARCH FOUNDATION, INC. | 2
| 2013
|
| OPHIDIAN PHARMACEUTICALS, INC. | 1
1 1 1 | 1995
1997 1998 1999 |
| CIRCLE 33, LLC | 1
1 1 | 2012
2013 2016 |
| PROMEGA CORPORATION | 1
1 1 1 2 2 | 1994
1995 1997 1998 1999 2003 |
Inventor Addresses
| Address | Duration |
|---|---|
| Fitchburg, WI | Sep 02, 03 - Sep 02, 03 |
| Fitchburg, WI, US | Oct 11, 12 - Jan 30, 18 |
| Madison, WI | Apr 07, 98 - Aug 28, 07 |
| Stoughton, WI, US | Sep 16, 21 - Aug 22, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 12 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 4 |
| C07D: | HETEROCYCLIC COMPOUNDS | 4 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0279,232 | 2024 | USE OF SUBSTITUTED 5-(4-METHYL-6-PHENYL-4H-BENZO[F]IMIDAZO[1,5-A][1,4] DIAZEPIN-3-YL)-1,2,4-OXADIAZOLES IN THE TREATMENT OF INFLAMMATORY CONDITIONS | 0 |
| 12054491 | 2024 | Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators | 0 |
| 2023/0103,216 | 2023 | GABA(A) RECEPTOR MODULATORS AND METHODS TO CONTROL AIRWAY HYPERRESPONSIVENESS AND INFLAMMATION IN ASTHMA | 0 |
| 11447495 | 2022 | Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators | 0 |
| 2021/0284,649 | 2021 | GABA(A) RECEPTOR MODULATORS AND METHODS TO CONTROL AIRWAY HYPERRESPONSIVENESS AND INFLAMMATION IN ASTHMA | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.